Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Aug;27(8):1596-1603.
doi: 10.1111/ene.14253. Epub 2020 May 13.

Trimethylamine-N-oxide is elevated in the acute phase after ischaemic stroke and decreases within the first days

C Schneider  1 , J G Okun  2 , K V Schwarz  2 , J Hauke  2 , M Zorn  3 , C Nürnberg  1 , M Ungerer  1 , P A Ringleb  1 , S Mundiyanapurath  1
Affiliations

Trimethylamine-N-oxide is elevated in the acute phase after ischaemic stroke and decreases within the first days

C Schneider et al. Eur J Neurol. 2020 Aug.

Erratum in

  • Corrigendum.
    [No authors listed] [No authors listed] Eur J Neurol. 2021 Aug;28(8):2812-2813. doi: 10.1111/ene.14825. Eur J Neurol. 2021. PMID: 34291531 No abstract available.

Abstract

Background and purpose: Trimethylamine-N-oxide (TMAO) is a biomarker of the gut microbiome and correlates with the risk of cardiovascular diseases. However, conflicting data exist on the specific role of TMAO in ischaemic stroke patients. We aimed to analyze the time course of TMAO levels in stroke patients compared with controls.

Methods: In this prospective, case-control study, patients suffering from ischaemic stroke (onset <24 h) and control patients with less than two cardiovascular risk factors were enrolled. Plasma TMAO levels were analyzed on admission, after 48 h and after 3 months. The primary endpoint was the difference in TMAO levels on admission between stroke patients and controls.

Results: A total of 196 patients with ischaemic stroke and 100 controls were included between February 2018 and April 2019. Plasma TMAO levels on admission were significantly higher in stroke patients than in controls [median value 4.09 (2.87-6.49) vs. 3.16 (2.08-5.16) µmol/L, P = 0.001]. There was a significant decrease in TMAO levels in stroke patients after 48 h [median at 48 h, 3.49 (2.30-5.39) µmol/L, P = 0.027]. TMAO levels increased again 3 months after stroke [median 4.23 (2.92-8.13) µmol/L, P = 0.047]. In controls, TMAO levels did not change between admission and after 48 h [median at 48 h, 3.14 (1.63-4.61) µmol/L, P = 0.11]. An inverse correlation between TMAO values and kidney function was found (Spearman rho -0.334, P < 0.001).

Conclusions: Our study emphasizes the importance of the time course of TMAO levels after ischaemic stroke. Future studies should define the time point of TMAO analysis, preferably in the acute phase (<24 h).

Keywords: gut microbiome; ischaemic stroke; liquid chromatography-tandem mass spectrometry; trimethylamine-N-oxide.

PubMed Disclaimer

References

    1. Nam HS. Gut microbiota and ischemic stroke: the role of trimethylamine N-oxide. J Stroke 2019; 21: 151-159.
    1. Hiergeist A, Reischl U, Gessner A. Multicenter quality assessment of 16S ribosomal DNA-sequencing for microbiome analyses reveals high inter-center variability. Int J Med Microbiol 2016; 306: 334-342.
    1. Swidsinski A, Dorffel Y, Loening-Baucke V, et al. Reduced mass and diversity of the colonic microbiome in patients with multiple sclerosis and their improvement with ketogenic diet. Front Microbiol 2017; 8: 1141.
    1. Zeisel SH, Warrier M. Trimethylamine N-oxide, the microbiome, and heart and kidney disease. Annu Rev Nutr 2017; 37: 157-181.
    1. Zhu W, Gregory JC, Org E, et al. Gut microbial metabolite TMAO enhances platelet hyperreactivity and thrombosis risk. Cell 2016; 165: 111-124.

Publication types

LinkOut - more resources